GlaxoSmithkline Consumer Healthcare has reported results for third quarter ended December 31, 2013.
The company has reported 14.50% rise in its net profit at Rs 79.75 crore for the quarter as compared to Rs 69.65 crore for the same quarter in the previous year. Total income of the company has increased by 18.70% at Rs 913.55 crore for quarter under review as compared to Rs 769.62 crore for the quarter ended December 31, 2012.
GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK, a global science based healthcare company. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.
The company has reported 14.50% rise in its net profit at Rs 79.75 crore for the quarter as compared to Rs 69.65 crore for the same quarter in the previous year. Total income of the company has increased by 18.70% at Rs 913.55 crore for quarter under review as compared to Rs 769.62 crore for the quarter ended December 31, 2012.
GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK, a global science based healthcare company. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.
No comments:
Post a Comment